Results 91 to 100 of about 88,938 (144)

Botulinum Toxin: A Breakthrough Treatment for Frey Syndrome

Clinical Dermatology Review
A 58-year-old male experienced gustatory sweating on the left side of his face for 2 years following a left parotidectomy a decade prior. He was clinically diagnosed with Frey syndrome, confirmed by a starch-iodine test.
S Dinesh Kumar, J Iswariya, Navya Donaparthi, Debdeep Mitra   +3 more
doaj   +1 more source

Lung Deposition of Inhaled Extrafine Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide in Healthy Volunteers and Asthma: The STORM Study. [PDF]

J Aerosol Med Pulm Drug Deliv, 2022
Usmani OS, Baldi S, Warren S, Panni I, Girardello L, Rony F, Taylor G, DeBacker W, Georges G.   +8 more
europepmc   +1 more source

Translational Study Searching for Synergy between Glycopyrronium and Indacaterol

, 2014
We aimed to explore whether the acute bronchodilation induced by indacaterol 150 μg and glycopyrronium bromide 50 μg is additive or synergistic with respect to monocomponents by testing the type of effect ex vivo on isolated human bronchi and then in ...
Matera MG, Cazzola M, Calzetta, L, Matera, M, Calzetta L, Cazzola, M, Rogliani P, ROGLIANI, PAOLA, Segreti A, Segreti, A, Facciolo, F, CAZZOLA, MARIO, SEGRETI, ANDREA, Rogliani, P, Matera, MG, MATERA, Maria Gabriella, Facciolo F, Matera, M.   +17 more
core   +1 more source

Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine. [PDF]

EJNMMI Res, 2021
Mohan V, Bruin NM, Tesselaar MET, de Boer JP, Vegt E, Hendrikx JJMA, Al-Mamgani A, van de Kamer JB, Sonke JJ, Vogel WV.   +9 more
europepmc   +1 more source

Feasible Fumigant-Herbicide System Alternatives to Methyl Bromide for Bell Pepper Producers [PDF]

With the current methyl bromide (MeBr) system for producing Georgia’s peppers being phased out, alternative fumigant and herbicide systems for producers are analyzed.
Fonsah, Esendugue Greg, Escalante, Cesar L., Byrd, Mark M., Wetzstein, Michael E.   +3 more
core  

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combination Treatment for Asthma. [PDF]

Adv Ther, 2022
Brittain D, D'Andrea P, Gruen E, Hosoe M, Jain D, Jauernig J, Pethe A, Scosyrev E, Tanase AM, Tillmann HC.   +9 more
europepmc   +1 more source

A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial. [PDF]

Br J Dermatol, 2021
Abels C, Soeberdt M, Kilic A, Reich H, Knie U, Jourdan C, Schramm K, Heimstaedt-Muskett S, Masur C, Szeimies RM.   +9 more
europepmc   +1 more source

Differential pharmacology and clinical utility of emerging combination treatments in the management of COPD – role of umeclidinium/vilanterol

International Journal of COPD, 2014
Mario Malerba,1 Jaymin Bhagwanji Morjaria,2 Alessandro Radaeli3 1Department of Internal Medicine, University of Brescia, Brescia, Italy; 2Department of Academic Respiratory Medicine, Hull York Medical School, University of Hull, Castle Hill Hospital ...
Malerba M, Morjaria JB, Radaeli A
doaj  

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]

, 2014
Buhl R, Banerji D. Int J Chron Obstruct Pulmon Dis. 2012;7:729–741. On page 737 in the first paragraph of the "Safety" section, the final sentence "Serious adverse events occurred with a slightly lower frequency in the glycopyrronium
Buhl R, Banerji D
core  

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study

, 2015
Chen Wang,1 Tieying Sun,1 Yijiang Huang,2 Michael Humphries,3 Lingyan Bai,3 Lilly Li,3 Qian Wang,3 Pearl Kho,4 Roz Firth,4 Peter D'Andrea51Beijing Hospital, Dongcheng District, Beijing, People's Republic of China; 2Hainan Provincial People's ...
Kho P, Huang Y, Wang Q, Wang C, Sun T, Firth R, D’Andrea P, Bai L, Humphries M, Li L   +9 more
core